Holen Sie sich die Stockscreener-App
0.1551
16.70%
-0.0311
Handel nachbörslich:
.16
0.0049
+3.16%
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
Tevogen Bio Signs Letter of Intent to Evaluate Potential Apozeal Pharmaceutical Acquisition - marketscreener.com
U.S. federal banking regulators clarify capital treatment rules for tokenized securities - Bitget
Tevogen Bio Holdings (Tevogen) has recently taken a key step in its generic drug business strategy, signing a letter of intent to officially begin evaluating the potential acquisition of Apozeal Pharmaceuticals. - Bitget
Tevogen Bio Holdings Inc is currently actively evaluating other transaction opportunities and has strategically focused its priorities on businesses related to the life sciences sector. - Bitget
Tevogen Bio Holdings Inc. Signs Letter of Intent to Explore Acquisition of Apozeal Pharmaceutical Inc. for Generics Expansion - Quiver Quantitative
Tevogen eyes 11 FDA-approved generics in Apozeal deal talks - Stock Titan
Tevogen Announces Reverse Stock Split - Bitget
TVGN Downgrade: Analyst Shifts Rating from Buy to Hold | TVGN St - GuruFocus
Tevogen Shares Plunge 22% After Reverse Stock Split Announcement - Nasdaq
Tevogen Bio Announces 1-for-50 Reverse Stock Split - TipRanks
1-for-50 Reverse Split Effective Mar 6, 2026 — Tevogen (NASDAQ: TVGN) - Stock Titan
Tevogen Bio (Nasdaq: TVGN) sets 1-for-50 reverse stock split to meet Nasdaq bid rule - Stock Titan
Tevogen announces reverse stock split - marketscreener.com
TVGN: Analyst Lowers Price Target by 60% While Maintaining Buy R - GuruFocus
D. Boral Capital lowers Tevogen Bio stock price target to $2 on dilution risk - Investing.com
Tevogen Bio Signs Letter of Intent to Explore Contract Research Organization Acquisition - marketscreener.com
Tevogen Bio Holdings Inc. Signs Non-Binding Letter of Intent to Explore Potential Transaction with Global Contract Research Organization - Quiver Quantitative
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization - ChartMill
UPDATETevogen Signs Letter of Intent to Evaluate - GlobeNewswire
Tevogen signs loi to evaluate potential acquisition of Sciometrix - marketscreener.com
Tevogen (NASDAQ: TVGN) approves reverse split and 100M plan increase - Stock Titan
Tevogen Bio Holdings Inc. Signs Letter of Intent to Explore Acquisition of Sciometrix Inc. for Enhanced Healthcare Solutions | TVGN Stock News - Quiver Quantitative
Tevogen weighs Sciometrix digital health deal that could bring in revenue - Stock Titan
Tevogen Bio Shareholders Approve Reverse Split Authorization - TipRanks
Ryan Saadi: Innovative Biotech Leader, Tevogen Bio Founder and CEO, and Champion of Accessible Immunotherapy - BBN Times
TVGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Inflation Data: Is NESR stock a buy or sell2025 Investor Takeaways & Growth Focused Entry Reports - baoquankhu1.vn
Is Psyence Biomedical Ltds ROIC above industry averageJuly 2025 News Drivers & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Tevogen Bio (TVGN) to Release Earnings on Wednesday - MarketBeat
Is Tevogen Bio Holdings Inc. a defensive stockShare Buyback & Consistent Return Investment Signals - mfd.ru
What is Tevogen Bio Holdings Inc.’s valuation compared to sectorJuly 2025 Gainers & Long Hold Capital Preservation Plans - mfd.ru
Tevogen Bio (NASDAQ:TVGN) Trading 7.9% HigherShould You Buy? - MarketBeat
Tevogen Bio (NASDAQ:TVGN) Trading 7.9% Higher – Should You Buy? - Defense World
Can Tevogen Bio Holdings Inc. Equity Warrant expand its profit margins2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - mfd.ru
Will Tevogen Bio Holdings Inc. stock continue upward momentumMarket Movement Recap & Consistent Income Trade Ideas - mfd.ru
Aug Rallies: Can Tevogen Bio Holdings Inc Equity Warrant maintain its current growth rate2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
How cyclical is Tevogen Bio Holdings Inc.’s revenue streamEarnings Performance Report & Capital Efficiency Focused Strategies - mfd.ru
What momentum indicators show for Tevogen Bio Holdings Inc. stockJuly 2025 WrapUp & Risk Controlled Swing Trade Alerts - mfd.ru
How risky is Tevogen Bio Holdings Inc. Equity Warrant stock nowTrade Volume Report & Fast Gain Stock Tips - mfd.ru
What are Tevogen Bio Holdings Inc.’s recent SEC filings showingWeekly Trade Review & Accurate Intraday Trading Signals - mfd.ru
Sentiment Review: Is CORT stock overvalued or fairly pricedJuly 2025 Action & High Accuracy Buy Signal Tips - baoquankhu1.vn
Why Tevogen Bio Holdings Inc. stock is a value investor pickJuly 2025 Analyst Calls & Real-Time Volume Analysis Alerts - mfd.ru
What’s the outlook for Tevogen Bio Holdings Inc.’s sectorJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - mfd.ru
Can Tevogen Bio Holdings Inc. Equity Warrant maintain its current growth rateQuarterly Earnings Report & Daily Technical Forecast Reports - mfd.ru
Is now the right time to enter Tevogen Bio Holdings Inc. Equity WarrantJobs Report & Technical Analysis for Trade Confirmation - mfd.ru
Should I buy Tevogen Bio Holdings Inc. Equity Warrant stock nowJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
Does Tevogen Bio Holdings Inc. Equity Warrant meet Warren Buffett’s criteriaWeekly Profit Recap & Momentum Based Trading Signals - mfd.ru
How geopolitical tensions affect Tevogen Bio Holdings Inc. Equity Warrant stockJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - mfd.ru
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders - BioSpace
Press Release: Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders - 富途牛牛
AI Stocks: Can Tevogen Bio Holdings Inc Equity Warrant maintain its current growth rateInsider Selling & Real-Time Buy Signal Alerts - baoquankhu1.vn
Tevogen board to evaluate potential special cash dividend By Investing.com - Investing.com India
VIX Spike: Can ADAG generate free cash flowQuarterly Investment Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Tevogen Evaluates Potential Special Cash Dividend - Intellectia AI
Tevogen Bio Holdings Inc Evaluates Special Cash Dividend - TradingView
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):